How to Cite
Abstract
Brain metastases are the most common intracranial malignancy accounting for significant morbidity and mortality in cancer patients. The current treatment paradigm for brain metastasis depends on patient’s overall health status, the primary tumor pathology and the number and location of brain lesions. Treatment of brain metastases should be individualized for each patient: in case of single brain metastasis surgery or radiosurgery should be considered as first options of treatment; in case of multiple lesions whole-brain radiotherapy is the standard of care in association with systemic therapy or surgery/radiosurgery. Herein, we review the modern management options for these tumors including surgical resection, radiotherapy. In the last decades TKIs or monoclonal antibodies have showed an increase in overall response rate and overall survival in Phase II-III trials. The aim of this paper is to make an overview of the current approaches in management of patients with brain metastases.References
Ветлова Е.Р, Антипина Н.А., Голанов А.В., Банов С.М. Роль лучевой терапии в лечении метастатического поражения головного мозга // Медицинская физика. - 2016. - №4. - C. 108-118.
Виртуальные нейрохирургические операции / Пицхелаури, Д.И., Галатенко, В.В., Баяковский, Ю.М., Самборский, Д.Я.Пицхелаури, Д.И., Галатенко, В.В., Баяковский, Ю.М., Самборский, Д.Я. - http://www. graphicon.ru/2008/proceedings/Russian/SR5/Paper_4. pdf: In GraphiCon, 2008.
Голанов А., Банов С., Ветлова Е. Метастатическое поражение головного мозга: изменение парадигмы лучевого лечения // Вопросы онкологии. - 2015. - Т. 61. - № 4. - C. 530-545.
Голанов А., Банов С., Ильялов С., Ветлова Е. и др. Современные подходы к лучевому лечению метастатического поражения головного мозга // Злокачественные опухоли. - 2014. - Т. 3(10). - C. 137-140.
Голанов А., Банов С., Ильялов С., Трунин Ю. и др. Радиохирургическое лечение метастазов в головной мозг. Факторы прогноза общей выживаемости и интракраниальных рецидивов // Вопросы нейрохирургии» имени Н.Н. Бурденко. - 2016. - Т. 80. - № 2. - C. 35-46.
Канаев С., Гиршович М., Мельник Ю. Клинический опыт радиохирургического лечения метастатического поражения головного мозга при злокачественных новообразованиях // Вопросы онкологии. - 2016. - № 2. - Т. 2. - C. 258-264
Магнитно-резонансная томография в нейрохирургии / Коновалов А.Н., Корниенко В.Н., Пронин И.Н.Коновалов А.Н., Корниенко В.Н., Пронин И.Н. -Москва: VIDAR, 1997. - 471 с.
Современные технологии и клинические исследования в нейрохирургии / Лошаков В.А., Кобяков Г.Л., Ветлова Е.Р, Голанов А.В. - Москва, 2012.
Ahluwalia M., Vogelbaum M., Chao S., Mehta M. Brain metastasis and treatment // F1000prime reports. - 2014. - Vol. 6. - P. 114.
Alexandru D., Bota D., Linskey M. Epidemiology of central nervous system metastases // Progress in neurological surgery. - 2012. - Vol. 25. - P. 13-29.
Ammirati M., Kshettry V., Lamki Т., Wei L. et al. A Prospective Phase II Trial of Fractionated Stereotactic Intensity Modulated Radiotherapy with or Without Surgery in the Treatment of Patients with 1 to 3 Newly Diagnosed Symptomatic Brain Metastases // Neurosurgery. - 2014. - Vol. 74. - № 6. - P. 586-594.
Andrews D., Scott C., Sperduto P., Flanders A. et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain me-tastases: phase III results of the RTOG 9508 randomised trial // Lancet (London, England). - 2004. - Vol. 363. - № 9422. - P. 1665-1672.
Aoyama H., Shirato H., Onimaru R., Kagei K. et al. Hypo-fractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull // International Journal of Radiation Oncology*Biology*Physics. - 2003. - Vol. 56. - № 3. - P. 793-800.
Aoyama H., Shirato H., Tago M., Nakagawa K. et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial // JAMA. - 2006. - Vol. 295. - № 21. - P. 2483-2491.
Bhangoo S., Linskey M., Kalkanis S. Evidence-based guidelines for the management of brain metastases // Neurosurgery clinics of North America. - 2011. - Vol. 22. - № 1. - P. 97.
Cameron D., Casey M., Press M., Lindquist D. et al. A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzum-ab: updated efficacy and biomarker analyses // Breast cancer research and treatment. - 2008. - Vol. 112. - № 3. - P. 533-543.
Ceresoli G., Cappuzzo F, Gregorc V., Bartolini S. et al. Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial // Annals of oncology: official journal of the European Society for Medical Oncology. - 2004. - Vol. 15. - № 7. - P. 1042-1047.
Chang E., Wefel J., Hess K., Allen P. et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial // The Lancet. Oncology. - 2009. - Vol. 10. - № 11. - P. 1037-1044.
Chang E., Wefel J., Maor M., Hassenbusch S. et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone // Neurosurgery. - 2007. - Vol. 60. - № 2. - P. 277-83. - discussion 283-4.
Chao J., Phillips R., Nickson J. Roentgen-ray therapy of cerebral metastases // Cancer. - 1954. - Vol. 7. - № 4. - P. 682-689.
Chen G., Huynh M., Chen A., Fehrenbacher L., et al., Chemotherapy for brain metastases in small-cell lung cancer // Clinical lung cancer. - 2008. - Vol. 9. - № 1. 34. - P. 35-38.
Dima Suki, Hiba Abouassi, Akash J. Patel, Raymond Sawaya, Jeffrey S. Weinberg, Morris D. Groves. Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa // Journal of neurosurgery. - 2008. - Vol. 108. - № 2. - P. 248-257.
Eaton B., Gebhardt B., Prabhu R., Shu H.-K. et al. Hy-pofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation // Radiation oncology (London, England). - 2013. - Vol. 8. - P. 135.
Ebi J., Sato H., Nakajima M., Shishido F. Incidence of leukoencephalopathy after whole-brain radiation therapy for brain metastases // International journal of radiation oncology, biology, physics. - 2013. - Vol. 85. - № 5. - P. 1212-1217.
Falchook G., Moulder S., Wheler J., Jiang Y et al. Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer // Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. - 2013. - Vol. 24. - № 12. - P. 3004-3011.
Flickinger J., Lunsford L., Kondziolka D. Dose-Volume Considerations in Radiosurgery // Stereotactic and Functional Neurosurgery. - 2004. - Vol. 57. - № 1-2. - P. 99-105.
Gaspar L., Scott C., Rotman M., Asbell S. et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials // International journal of radiation oncology, biology, physics. - 1997. - Vol. 37. - № 4. - P. 745-751.
Gonzalez-Cao M., Viteri S., Diaz-Lagares A., Gonzalez A. et al. Preliminary results of the combination of bevaci-zumab and weekly Paclitaxel in advanced melanoma // Oncology. - 2008. - Vol. 74. - № 1-2. - P. 12-16.
Gore E., Bae K., Wong S., Sun A. et al. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214 // Journal of clinical oncology: official journal of the American Society of Clinical Oncology. - 2011. - Vol. 29. - № 3. - P. 272-278.
Hanssens P., Karlsson B., Yeo T, Chou N. et al. Detection of brain micrometastases by high-resolution stereotactic magnetic resonance imaging and its impact on the timing of and risk for distant recurrences // Journal of neurosurgery. - 2011. - Vol. 115. - № 3. - P. 499-504.
Inoue H., Sato H., Suzuki Y, Saitoh J.-i. et al. Optimal hypofractionated conformal radiotherapy for large brain metastases in patients with high risk factors: a single-institutional prospective study // Radiation oncology (London, England). - 2014. - Vol. 9. - P. 231.
Khasraw M., Holodny A., Goldlust S., DeAngelis L. Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience // Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. - 2012. - Vol. 23. - № 2. - P. 458-463.
Kim Y-J., Cho K., Kim J.-Y, Lim Y et al. Single-dose versus fractionated stereotactic radiotherapy for brain metastases // International journal of radiation oncology, biology, physics. - 2011. - Vol. 81. - № 2. - P. 483-489.
Kocher M., Soffietti R., Abacioglu U., Villa S., et al., Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study // Journal of clinical oncology: official journal of the American Society of Clinical Oncology. - 2011. - Vol. 29. - № 2. - P. 134-141.
Kocher M., Wittig A., Piroth M., Treuer H. et al. Stereotactic radiosurgery for treatment of brain metastases // Strahlentherapie und Onkologie. - 2014. - Vol. 190. - № 6. - P. 521-532.
Kondziolka D., Patel A., Lunsford L., Kassam A., et al., Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases // International journal of radiation oncology, biology, physics. - 1999. - Vol. 45. - № 2. - P. 427-434.
Kwon A., Dibiase S., Wang B., Hughes S. et al. Hypo-fractionated stereotactic radiotherapy for the treatment of brain metastases // Cancer. - 2009. - Vol. 115. - № 4. - P. 890-898.
Langley R., Stephens R., Nankivell M., Pugh C. et al. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from nonsmall cell lung cancer? // Clinical oncology (Royal College of Radiologists (Great Britain)). - 2013. - Vol. 25. - № 3. - e23-30.
Lin N., Lee E., Aoyama H., Barani I. et al. Response assessment criteria for brain metastases // The Lancet Oncology. - 2015. - Vol. 16. - № 6. - e270-e278.
Lippitz B., Lindquist C., Paddick I., Peterson D. et al. Stereotactic radiosurgery in the treatment of brain metastases // Cancer Treatment Reviews. - 2014. - Vol. 40. - № 1. - P. 48-59.
Lippitz B. State of the Art of Gamma Knife Radiosurgery // Overview of Current Practice and Review of the 17th International Leksell Gamma. - p.10.
Long G., Trefzer U., Davies M., Kefford R. et al. Dab-rafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB) // The Lancet Oncology. - 2012. - Vol. 13. - № 11. - P. 1087-1095.
Marchan E., Sheehan J. Stereotactic radiosurgery of brain metastasis from melanoma // Progress in neurological surgery. - 2012. - Vol. 25. - P. 176-189.
Marchetti M., Milanesi I., Falcone C., Santis M. de et al. Hypofractionated stereotactic radiotherapy for oligome-tastases in the brain // Neurological Sciences. - 2011. - Vol. 32. - № 3. - P. 393-399.
Mulvenna P., Nankivell M., Barton R., Faivre-Finn C. et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with nonsmall cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ) // The Lancet. - 2016. - Vol. 388. - № 10055. - P. 2004-2014.
Nabors L., Portnow J., Ammirati M., Brem H., et al., Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines // Journal of the National Comprehensive Cancer Network: JNCCN. - 2014. - Vol. 12. - № 11. - P. 1517-1523.
Nagai A., Shibamoto Y, Mori Y, Hashizume C. et al. Increases in the number of brain metastases detected at frame-fixed, thin-slice MRI for gamma knife surgery planning // Neuro-oncology. - 2010. - Vol. 12. - № 11. - P. 1187-1192.
Narita Y, Shibui S. Strategy of surgery and radiation therapy for brain metastases // International journal of clinical oncology. - 2009. - Vol. 14. - № 4. - P. 275-280.
Nathoo N., Chahlavi A., Barnett G., Toms S. Pathobiology of brain metastases // Journal of clinical pathology. - 2005. - Vol. 58. - № 3. - P. 237-242.
Patchell R. The management of brain metastases // Cancer Treatment Reviews. - 2003. - Vol. 29. - № 6. - P. 533-540.
Patchell R., Tibbs P., Regine W., Dempsey R. et al. Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain // JAmA. - 1998. - Vol. 280. - № 17.
Patchell R., Tibbs P., Walsh J., Dempsey R. et al. A randomized trial of surgery in the treatment of single metas-tases to the brain // The New England journal of medicine. - 1990. - Vol. 322. - № 8. - P. 494-500.
Patel T., Knisely J., Chiang V. Management of brain metastases: surgery, radiation, or both? // Hematology/ oncology clinics of North America. - 2012. - Vol. 26. - № 4. - P. 933-947.
Pivot X., Manikhas A., Zurawski B., Chmielowska E. et al. CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastu-zumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer // Journal of clinical oncology: official journal of the American Society of Clinical Oncology. - 2015. - Vol. 33. - № 14. - P. 1564-1573.
Pollock B., Brown P., Foote R., Stafford S. et al. Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease // Journal of neuro-oncology. - 2003. - Vol. 61. - № 1. - P. 73-80.
Porta R., Sanchez-Torres J., Paz-Ares L., Massuti B. et al. Brain metastases from lung cancer responding to er-lotinib: the importance of EGFR mutation // The European respiratory journal. - 2011. - Vol. 37. - № 3. - P. 624-631.
Ranasinghe M., Sheehan J. Surgical management of brain metastases // Neurosurgical FOCUS. - 2007. - Vol. 22. - № 3. - E2.
Regine W., Scott C., Murray K., Curran W. Neurocogni-tive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfraction-ated radiotherapy // International Journal of Radiation Oncology*Biology*Physics. - 2001. - Vol. 51. - № 3. - P. 711-717.
Roberge D., Petrecca K., El Refae M., Souhami L. Whole-brain radiotherapy and tumor bed radiosurgery following resection of solitary brain metastases // Journal of neurooncology. - 2009. - Vol. 95. - № 1. - P. 95-99.
Sahgal A., Soliman H., Larson D. Whole-brain radiation therapy of brain metastasis // Progress in neurological surgery. - 2012. - Vol. 25. - P. 82-95.
Shaffrey M., Mut M., Asher A., Burri S. et al. Brain metastases // Current problems in surgery. - 2004. - Vol. 41. - № 8. - P. 665-741.
Shehata M., Young B., Reid B., Patchell R. et al. Ste-reotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy // International journal of radiation oncology, biology, physics. - 2004. - Vol. 59. - № 1. - P. 87-93.
Slotman B., Mauer M., Bottomley A., Faivre-Finn C. et al. Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer // Journal of Clinical Oncology. - 2008. - Vol. 27. - № 1. - P. 78-84.
Smalley S., Schray M., Laws E., O'Fallon J. Adjuvant radiation therapy after surgical resection of solitary brain metastasis // International Journal of Radiation Oncology*Biology*Physics. - 1987. - Vol. 13. - № 11. - P. 1611-1616.
Sperduto P., Shanley R., Luo X., Andrews D. et al. Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA) // International journal of radiation oncology, biology, physics. - 2014. - Vol. 90. - № 3. - P. 526-531.
Steeg P., Camphausen K., Smith Q. Brain metastases as preventive and therapeutic targets // Nature reviews. Cancer. - 2011. - Vol. 11. - № 5. - P. 352-363.
Truong M., St Clair E., Donahue B., Rush S. et al. Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery // Neurosurgery. - 2006. - Vol. 59. - № 1. - P. 86-97.
Tsao M., Xu W., Sahgal A. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases // Cancer. - 2012. - Vol. 118. - № 9. - P. 2486-2493.
Tye K., Engelhard H., Slavin K., Nicholas M. et al. An analysis of radiation necrosis of the central nervous system treated with bevacizumab // Journal of neuro-oncology. - 2014. - Vol. 117. - № 2. - P. 321-327.
Vogelbaum M., Suh J. Resectable brain metastases // Journal of clinical oncology: official journal of the American Society of Clinical Oncology. - 2006. - Vol. 24. - № 8. - P. 1289-1294.
Yamamoto M., Kawabe T., Sato Y, Higuchi Y et al. Stereotactic radiosurgery for patients with multiple brain metas-tases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors // Journal of neurosurgery. - 2014. - Vol. 121 Suppl. - P. 16-25.
Yoo H., Kim Y, Nam B., Shin S. et al. Reduced local recurrence of a single brain metastasis through microscopic total resection // Journal of neurosurgery. - 2009. - Vol. 110. - № 4. - P. 730-736.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2017